Table 5.
Factor level | Risk factor | Crude OR | Adjusted OR | (95% CI) | P-value |
---|---|---|---|---|---|
Background | Age (continuous per year) | 0.91* | 0.93 | (0.86–1.0) | .068 |
District of residence | |||||
Kampala | 1.0 | 1.0 | |||
Wakiso | 0.86 | 0.98 | (0.45–2.13) | .97 | |
Other | 0.21 | 0.21 | (0.01–1.06) | .14 | |
Education (continuous per level) | 1.1 | 1.05 | (0.61–1.81) | .87 | |
Intermediate | Gravidity | ||||
G1 | 1.0 | 1.0 | |||
G2-3 | 0.69 | 1.22 | (0.54–2.77) | .63 | |
≥G4 | 0.30* | 0.70 | (0.14–3.51) | .67 | |
Placental malaria (active + past) | 1.48 | 0.72 | (0.29–1.80) | .48 | |
Active infection | 1.61 | 0.69 | (0.24–1.96) | .49 | |
Past infection | 1.05 | 0.77 | (0.16–3.77) | .75 | |
Haemoglobin level | 0.83* | 0.83 | (0.70–0.99) | .033 | |
Proximate | Use of bednet | 1.33 | 1.65 | (0.72–3.79) | .24 |
Received IPT | |||||
None | 1.0 | 1.0 | |||
1 dose of SP | 1.20 | 1.21 | (0.56–2.63) | .63 | |
2 doses of SP | 0.84 | 0.96 | (0.30–3.09) | .94 | |
Iron supplementation | 0.74 | 0.19 | (0.02–1.58) | .12 | |
Folic acid supplementation | 1.0 | 4.48 | (0.57–34.9) | .15 |
*Significant associations (P < .05).